Autophagy is an evolutionarily conserved process that has both cytoprotective and cell death functions. [2] [3] [4] [5] Beclin 1 is a tightly regulated haploinsufficient tumor suppressor, which is part of a class III phosphatidlyinositol 3-kinase (PI3K) multiprotein complex that participates in autophagosomes nucleation. 6 The autophagy-promoting activity of Beclin 1 is suppressed by antiapoptotic members of the Bcl-2 family through direct binding. Beclin 1 is a bona fide BH3-only protein, and the α-helix of its BH3 domain binds to the hydrophobic groove in Bcl-X L , similar to the interactions previously shown for other BH3 only proteins. [7] [8] [9] [10] [11] Under normal steady state growth conditions, Beclin 1 is bound to various Bcl-2 family members, whereas its dissociation from Bcl-2 mediates autophagy. 7 We recently discovered that Beclin 1 is a substrate for DAPk. 1 DAPk, a calcium/calmodulin Ser/Thr kinase, functions as a tumor suppressor gene and has been linked to several cell death pathways, including autophagic cell death. Using pull-down assays, as well as immunoprecipitation experiments, we show that DAPk physically interacts with Beclin 1. Interestingly, DAPk cannot bind a mutant Beclin 1 lacking the Bcl-2 binding domain, implying that this domain is required for the DAPk-Beclin 1 interaction. Using in vitro kinase assays, we show that DAPk phosphorylates Beclin 1, and map the phosphorylation site to T119 by peptide phosphorylation assays, mass spectrometry mapping, and the use of phospho-specific antibodies.
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T119 is located within Beclin 1's BH3 domain. We show that DAPk significantly reduces the amounts of Bcl-X L , which are immunoprecipitated by wild-type Beclin 1, leading to autophagy, whereas it fails to reduce Bcl-X L binding to the T119A phosphosilencing mutant. Conversely, the T119E phospho-mimicking mutant displays a weaker association with Bcl-X L , and induces autophagy when overexpressed. These results suggest that phosphorylation on T119 by DAPk leads to Beclin 1's dissociation from its inhibitor, Bcl-X L , resulting in autophagy induction.
The interaction between BH3-only proteins and the anti-apoptotic Bcl-2 members is mediated by hydrophobic and electrostatic interactions between the amphipathic α-helix of the BH3 domain, and a hydrophobic pocket formed by the BH1-3 domains of the anti-apoptotic Bcl-2 proteins. T119 is a residue unique to Beclin 1's BH3 domain. Other BH3-only proteins contain a hydrophobic residue in the corresponding position, which acts together with three additional hydrophobic residues present in their BH3 amphipathic α-helix, to stabilize the interaction with local hydrophobic pockets within the large target-binding groove. The lack of a hydrophobic amino acid at position 119 in Beclin 1 might explain why Beclin 1's binding to Bcl-X L is weaker than that of other BH3-only proteins. 10 Interestingly, substituting T119 in Beclin 1 to isoleucine enhances its association with Bcl-X L , confirming that this is a critical site in the interface between Beclin 1 and its inhibitors. 10 Our recently published data show that this www.landesbioscience.com Autophagycritical site is in fact a target of tight regulation by phosphorylation, causing a severe clash in the interaction with Bcl-X L .
We next examined whether phosphorylation on T119 also affects the interaction of Beclin 1 with Bcl-2. We first compared in silico the amino acids in Bcl-X L that form the binding pocket of T119 to the corresponding residues in Bcl-2 (Fig. 1) . We found that these residues are conserved in Bcl-2, except for the solventexposed A104 in Bcl-X L , which is replaced by the acidic D108 in Bcl-2. Therefore, the T119 binding pocket is predicted to be very similar in Bcl-X L and Bcl-2, and phosphorylation of T119 will most likely lead to similar disruption of the binding between Beclin 1 and Bcl-2. Moreover, the presence of an additional negative charge (D108) in Bcl-2 suggests that it may repel phosphorylated Beclin 1 even more than Bcl-X L .
To further investigate whether the T119 phosphorylation reduces association of Beclin 1 and Bcl-2, we used the phosphomimicking (T119E) and phospho-silencing (T119A) mutants of Beclin 1 and tested their binding to Bcl-2, as compared to the wild-type Beclin 1. HEK293T cells were cotransfected with Flagtagged Beclin 1 and Bcl-2, and the anti-Flag immunoprecipitates were immunoblotted with anti-Bcl-2 antibodies. The threonine to glutamic acid substitution at position 119 strongly reduced the binding of Beclin 1 to Bcl-2 (Fig. 2) . These results suggest that phosphorylation on T119 also reduces the association of Beclin 1 with Bcl-2.
Notably, it has been recently reported that phosphorylation of Bcl-2 by JNK1, at residues T69, S70 and S87 located within the unstructured loop of Bcl-2, is another mechanism which reduces the interaction between Beclin 1 and its inhibitor. 12 Taken together with our results, it is suggested here that the interaction between Beclin 1 and its inhibitors is dynamic, and subjected to regulation by phosphorylation of either one of the two partners in this complex (Fig. 3) . One event is the DAPk-mediated phosphorylation on the T119 residue of Beclin 1, and the other is the JNK-1-dependent phosphorylation at residues T69, S70 and S87 of Bcl-2. Future experiments should test whether these post-translational modifications on Beclin 1 and on its inhibitors occur simultaneously or are mutually exclusive. To this end, we will examine the state of the two phosphorylation events in response to different autophagic inducers. In case both proteins are phosphorylated simultaneously, possible synergistic effects leading Interaction of Beclin 1 with Bcl-2/Bcl-X L is regulated by DAPk Figure 1 . The binding cavity of T119 as observed in the Bcl-X L -Beclin 1 complex. (Protein Data Bank code 2p1l). Beclin 1 is colored in green, blue and red for carbon, oxygen and nitrogen atoms, respectively. T119 is emphasized (ball and stick presentation) and the stabilizing hydrogen bond between T119/Oγ and the BH3 helix backbone is indicated by a red line. Bcl-X L is shown in yellow with the side chains of the residues that form the hydrophobic T119 binding pocket indicated. All these residues are conserved in Bcl-2, except for the exposed A104, which is replaced by D. to a more severe effect on the interaction between Beclin 1 and its inhibitors will be tested using the phospho-mimicking mutants of Bcl-2 and Beclin 1. Answers to these questions will significantly advance our understanding of the regulation of Beclin 1 and autophagy induction.
